Acepodiaincis A Clinical Stage Biotechnology Company Based In Grand Caymancayman Islandsdedicated To Developing Next Generation Cell Therapies For Cancer And Autoimmune Diseasesthe Company Utilizes Its Proprietary Antibody Cell Conjugationaccand Antibody Drug Conjugatead2Cplatforms To Create Innovative Treatments That Aim To Be Both Effective And Accessible To Patients Acepodia S Clinical Pipeline Includes Several Candidatessuch As Ace1831An Anti Cd20 Therapy In Phase 1 Trials For Hematological Cancersand Ace2016Which Targets Egfr Positive Solid Tumorsthe Company Is Also Advancing Ace1702An Anti Her2 Therapy In Phase 1 Trialsand Has Preclinical Programs Focused On Gpc3 Positive Hepatocellular Carcinomaacepodia Collaborates With Pfizer To Develop Acc Based Therapies For Autoimmune Diseasesreflecting Its Commitment To Expanding Treatment Optionsthe Leadership Team Includes Drshih Chia Hsiaodryuhmin Yangand Yajun Wangamong Othersand The Company Operates In Taiwan And The U S
No conferences found for this company.
| Company Name | Acepodia Biotech Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
